Sfoglia per Autore
Health care costs of influenza-related episodes in high income countries: a systematic review
2018 Federici, CARLO BALDASSARRE; Cavazza, Marianna; Costa, Francesco; Jommi, Claudio
La spesa sanitaria: composizione ed evoluzione
2019 Armeni, Patrizio; Bertolani, Arianna; Borsoi, Ludovica; Costa, Francesco
Dinamiche economiche e performance del settore dei dispositivi medici in Italia
2019 Armeni, Patrizio; Costa, Francesco; Callea, Giuditta; Borsoi, Ludovica; Cavallo, Maria Caterina; Ciani, Oriana; Federici, Carlo; Tarricone, Rosanna; Torbica, Aleksandra
Implementation of value-based pricing for medicines
2020 Jommi, Claudio; Armeni, Patrizio; Costa, Francesco; Bertolani, Arianna; Otto, Monica
Cost-effectiveness and net monetary benefit of durvalumab consolidation therapy versus no consolidation therapy after chemoradiotherapy in stage III non–small cell lung cancer in the Italian National Health Service
2020 Armeni, Patrizio; Borsoi, Ludovica; Fornaro, Giulia; Jommi, Claudio; Grossi, Francesco; Costa, Francesco
Cost-effectiveness and net monetary benefit of Olaparib maintenance therapy versus no maintenance therapy after first-line platinum-based chemotherapy in newly diagnosed advanced BRCA1/2-mutated ovarian cancer in the Italian National Health Service
2020 Armeni, Patrizio; Borsoi, Ludovica; Fornaro, Giulia; Jommi, Claudio; Colombo, Nicoletta; Costa, Francesco
Programmi di early access dei farmaci e managed entry agreement in Italia: i risultati di un Focus Group (programmi di early access e managed entry agreement)
2021 Jommi, Claudio; Armeni, Patrizio; Costa, Francesco; Alberti, Chiara; Bandello, Francesco; Bordonaro, Roberto; Caprodossi, Andrea; Di Maio, Massimo; Gaudioso, Antonio; Giuliani, Giovanni; Langella, Roberto; Marata, Anna Maria; Patarnello, Francesca; Pinto, Carmine; Rasi, Guido; Villa, Federico
Establishing a national HTA program for medical devices in Italy: overhauling a fragmented system to ensure value and equal access to new medical technologies
2021 Tarricone, Rosanna; Amatucci, Fabio; Armeni, Patrizio; Banks, Helen; Borsoi, Ludovica; Callea, Giuditta; Ciani, Oriana; Costa, Francesco; Federici, Carlo; Torbica, Aleksandra; Marletta, Marcella
The future of Funds for Innovative Medicines: results from a Delphi Study
2021 Jommi, Claudio; Armeni, Patrizio; Bertolani, Arianna; Costa, Francesco; Otto, Monica
Report n. 42 OSFAR (Osservatorio Farmaci)
2022 Jommi, Claudio; Otto, MONICA HILDEGARD; Armeni, Patrizio; Costa, Francesco; Malandrini, FRANCESCO BENITO; Tarantola, Alice
Digitalizzazione nelle tecnologie per la salute: impatto sui livelli di governo del SSN
2022 Armeni, Patrizio; Costa, Francesco; Milano, Carlo; Segantin, Gaia
The invisible costs of obstructive sleep apnea (OSA): systematic review and cost-of-illness analysis
2022 Borsoi, Ludovica; Armeni, Patrizio; Donin, Gleb; Costa, Francesco; Ferini-Strambi, Luigi
Use of resource modeling to quantify the organizational impact of subcutaneous formulations for the treatment of oncologic patients: the case of daratumumab in multiple myeloma
2022 Federici, Carlo; Rognoni, Carla; Costa, Francesco; Armeni, Patrizio; Crovato, Elisa; Bellucci, Stefania
Early access programs for medicines: comparative analysis among France, Italy, Spain, and UK and focus on the Italian case
2023 Tarantola, Alice; Otto, Monica Hildegard; Armeni, Patrizio; Costa, Francesco; Malandrini, Francesco; Jommi, Claudio
Economic impact of a more extensive use of FENO testing on the Italian population with asthma
2023 Rognoni, Carla; Milano, Carlo; Heffler, Enrico; Bonini, Matteo; Brussino, Luisa; Carpagnano, Giovanna Elisiana; Ricciardolo, Fabio Luigi Massimo; Costa, Francesco; Armeni, Patrizio
Cost-effectiveness analysis of pressure-controlled intermittent coronary sinus occlusion in elective percutaneous coronary intervention
2023 Rognoni, Carla; Segantin, Gaia; Scarsini, Roberto; Valgimigli, Marco; Loizzi, Francesco; Costa, Francesco; Armeni, Patrizio
Cost-utility analysis of esketamine for patients with treatment resistant depression in Italy
2023 Rognoni, Carla; Falivena, Camilla; Costa, Francesco; Armeni, Patrizio
Pharmaceutical pricing and managed entry agreements: An exploratory study on future perspectives in Europe
2023 Jommi, Claudio; Bertolani, Arianna; Armeni, Patrizio; Costa, Francesco; Otto, Monica
Cost-effectiveness analysis of HRD testing for previously treated patients with advanced ovarian cancer in Italy
2024 Rognoni, Carla; Lorusso, Domenica; Costa, Francesco; Armeni, Patrizio
Titolo | Data di pubblicazione | Autore(i) | Rivista | Editore |
---|---|---|---|---|
Health care costs of influenza-related episodes in high income countries: a systematic review | 1-gen-2018 | Federici, CARLO BALDASSARRE; Cavazza, Marianna; Costa, Francesco; Jommi, Claudio | PLOS ONE | - |
La spesa sanitaria: composizione ed evoluzione | 1-gen-2019 | Armeni, Patrizio; Bertolani, Arianna; Borsoi, Ludovica; Costa, Francesco | - | Egea |
Dinamiche economiche e performance del settore dei dispositivi medici in Italia | 1-gen-2019 | Armeni, Patrizio; Costa, Francesco; Callea, Giuditta; Borsoi, Ludovica; Cavallo, Maria Caterina; Ciani, Oriana; Federici, Carlo; Tarricone, Rosanna; Torbica, Aleksandra | - | Egea |
Implementation of value-based pricing for medicines | 1-gen-2020 | Jommi, Claudio; Armeni, Patrizio; Costa, Francesco; Bertolani, Arianna; Otto, Monica | CLINICAL THERAPEUTICS | - |
Cost-effectiveness and net monetary benefit of durvalumab consolidation therapy versus no consolidation therapy after chemoradiotherapy in stage III non–small cell lung cancer in the Italian National Health Service | 1-gen-2020 | Armeni, Patrizio; Borsoi, Ludovica; Fornaro, Giulia; Jommi, Claudio; Grossi, Francesco; Costa, Francesco | CLINICAL THERAPEUTICS | - |
Cost-effectiveness and net monetary benefit of Olaparib maintenance therapy versus no maintenance therapy after first-line platinum-based chemotherapy in newly diagnosed advanced BRCA1/2-mutated ovarian cancer in the Italian National Health Service | 1-gen-2020 | Armeni, Patrizio; Borsoi, Ludovica; Fornaro, Giulia; Jommi, Claudio; Colombo, Nicoletta; Costa, Francesco | CLINICAL THERAPEUTICS | - |
Programmi di early access dei farmaci e managed entry agreement in Italia: i risultati di un Focus Group (programmi di early access e managed entry agreement) | 1-gen-2021 | Jommi, Claudio; Armeni, Patrizio; Costa, Francesco; Alberti, Chiara; Bandello, Francesco; Bordonaro, Roberto; Caprodossi, Andrea; Di Maio, Massimo; Gaudioso, Antonio; Giuliani, Giovanni; Langella, Roberto; Marata, Anna Maria; Patarnello, Francesca; Pinto, Carmine; Rasi, Guido; Villa, Federico | RECENTI PROGRESSI IN MEDICINA | - |
Establishing a national HTA program for medical devices in Italy: overhauling a fragmented system to ensure value and equal access to new medical technologies | 1-gen-2021 | Tarricone, Rosanna; Amatucci, Fabio; Armeni, Patrizio; Banks, Helen; Borsoi, Ludovica; Callea, Giuditta; Ciani, Oriana; Costa, Francesco; Federici, Carlo; Torbica, Aleksandra; Marletta, Marcella | HEALTH POLICY | - |
The future of Funds for Innovative Medicines: results from a Delphi Study | 1-gen-2021 | Jommi, Claudio; Armeni, Patrizio; Bertolani, Arianna; Costa, Francesco; Otto, Monica | GLOBAL & REGIONAL HEALTH TECHNOLOGY ASSESSMENT | - |
Report n. 42 OSFAR (Osservatorio Farmaci) | 1-gen-2022 | Jommi, Claudio; Otto, MONICA HILDEGARD; Armeni, Patrizio; Costa, Francesco; Malandrini, FRANCESCO BENITO; Tarantola, Alice | - | Egea |
Digitalizzazione nelle tecnologie per la salute: impatto sui livelli di governo del SSN | 1-gen-2022 | Armeni, Patrizio; Costa, Francesco; Milano, Carlo; Segantin, Gaia | - | Egea |
The invisible costs of obstructive sleep apnea (OSA): systematic review and cost-of-illness analysis | 1-gen-2022 | Borsoi, Ludovica; Armeni, Patrizio; Donin, Gleb; Costa, Francesco; Ferini-Strambi, Luigi | PLOS ONE | - |
Use of resource modeling to quantify the organizational impact of subcutaneous formulations for the treatment of oncologic patients: the case of daratumumab in multiple myeloma | 1-gen-2022 | Federici, Carlo; Rognoni, Carla; Costa, Francesco; Armeni, Patrizio; Crovato, Elisa; Bellucci, Stefania | CLINICAL THERAPEUTICS | - |
Early access programs for medicines: comparative analysis among France, Italy, Spain, and UK and focus on the Italian case | 1-gen-2023 | Tarantola, Alice; Otto, Monica Hildegard; Armeni, Patrizio; Costa, Francesco; Malandrini, Francesco; Jommi, Claudio | JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE | - |
Economic impact of a more extensive use of FENO testing on the Italian population with asthma | 1-gen-2023 | Rognoni, Carla; Milano, Carlo; Heffler, Enrico; Bonini, Matteo; Brussino, Luisa; Carpagnano, Giovanna Elisiana; Ricciardolo, Fabio Luigi Massimo; Costa, Francesco; Armeni, Patrizio | RESPIRATORY RESEARCH | - |
Cost-effectiveness analysis of pressure-controlled intermittent coronary sinus occlusion in elective percutaneous coronary intervention | 1-gen-2023 | Rognoni, Carla; Segantin, Gaia; Scarsini, Roberto; Valgimigli, Marco; Loizzi, Francesco; Costa, Francesco; Armeni, Patrizio | EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH | - |
Cost-utility analysis of esketamine for patients with treatment resistant depression in Italy | 1-gen-2023 | Rognoni, Carla; Falivena, Camilla; Costa, Francesco; Armeni, Patrizio | PHARMACOECONOMICS | - |
Pharmaceutical pricing and managed entry agreements: An exploratory study on future perspectives in Europe | 1-gen-2023 | Jommi, Claudio; Bertolani, Arianna; Armeni, Patrizio; Costa, Francesco; Otto, Monica | HEALTH POLICY AND TECHNOLOGY | - |
Cost-effectiveness analysis of HRD testing for previously treated patients with advanced ovarian cancer in Italy | 1-gen-2024 | Rognoni, Carla; Lorusso, Domenica; Costa, Francesco; Armeni, Patrizio | ADVANCES IN THERAPY | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile